JURA Bio

An autoimmune disease is triggered by the immune system turning against the body it is designed to protect from invading pathogens. Pathologic immune cells attack the body’s own tissue, triggering a cascade of events that cause damage to the targeted tissue.

At JURA Bio, we are creating a novel therapeutic platform of cell therapies meant to target those pathogenic immune cells. We have developed a disruptive treatment approach that harnesses the body’s immune synapses to target and neutralize pathologic cells interrupting the cascade. Please reach out to find out more.